References
- Kayukawa Y, Shirakawa S, Hayakawa T, Imai M, Iwata N, Ozaki N, et al. Habitual snoring in an outpatient population in Japan. Psych Clin Neurosci 2000; 54: 385–91
- Teculescu D, Hannhart B, Cornette A, Montaut-Verient B, Virion JM, Michaely JP. Prevalence of habitual snoring in a sample of French males. Role of “minor” nose-throat abnormalities. Respiration 2001; 68: 365–70
- Lindberg E, Taube A, Janson C, Gislason T, Svärdsudd K, Boman G. A 10-year follow-up of snoring in men. Chest 1998; 114: 1048–55
- Friberg D. Heavy snorer's disease: a progressive local neuropathy. Acta Otolaryngol 1999; 119: 925–33
- Paulsen P, Steven P, Tsokos M, Jungmann K, Müller A, Verse T, et al. Upper airway epithelial changes in obstructive sleep-disordered breathing. Am J Crit Care Med 2002; 166: 501–9
- Hamans EP, Van Marck E, De Backer WA, Creten W, Van de Heyning PH. Morphometric analysis of the uvula in patients with sleep-related breathing disorders. Eur Arch Otorhinolaryngol 2000; 257: 232–6
- Berkowitz RB, Bernstein DI, LaForce C, Pedinoff AJ, Rooklin AR, Damaraju CR, et al. Onset of action of mometasone furoate nasal spray (Nasonex) in seasonal allergic rhinitis. Allergy 1999; 54: 64–9
- Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnea in patients with co-existing rhinitis. Thorax 2004; 59: 50–5
- Stahn C, Löwenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 2007; 275: 71–8
- Mygind N, Nielsen LP, Hoffmann HJ, Shukla A, Blumberga G, Dahl R, et al. Mode of action of intranasal corticosteroids. J Allergy Clin Immunol 2001; 108(1 suppl)16–25
- Berlucchi M, Salsi D, Valetti L, Parrinello G, Nicolai P. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics 2007; 119: e1392–7
- Scharf MB, Cohen AP. Diagnostic and treatment implications of nasal obstruction in snoring and obstructive sleep apnea. Ann Allergy Asthma Immunol 1998; 81: 279–87
- Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med 2001; 161: 1514–9
- Friedman M, Gurpinar B, Lin HC, Schalch P, Joseph NJ. Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Ann Otol Rhinol Laryngol 2007; 116: 805–11
- Olofsson K, Mattsson C, Hammarström ML, Hellström S. Structure of the human uvula. Acta Otolaryngol 1999; 119: 712–7
- Berger G, Gilbey P, Hammel I, Ophir D. Histopathology of the uvula and the soft palate in patients with mild, moderate, and severe obstructive sleep apnea. Laryngoscope 2002; 112: 357–63
- Kim JW, Yoon IY, Chung S, Hee Lee C, Moon SJ, Yun PY. Comparison between tongue base and soft palate obstruction in obstructive sleep apnea. Acta Otolaryngol 2008; 31: 1–7
- Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids – lessons for the new millennium. Drug Safety 2000; 23: 11–33
- Onrust SV, Lamb HM. Mometasone furoate – a review of its intranasal use in allergic rhinitis. Drugs 1998; 56: 725–45
- Grunstein RR, Hedner J, Grote L. Treatment options for sleep apnoea. Drugs 2001; 61: 237–51